Sentinus, LLC
- SEC CIK
- 0001811345
- Latest filing
- Aug 11, 2026
NWBO holding history
Northwest Biotherapeutics Inc in every 13F filed by Sentinus, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NWBO overviewAll 13F holders of NWBOFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −12,925−100.0% | Sold out | Holders |
| Q4 2024 | 12,925 | $3.55K | <0.1% | +12,925 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −12,925−100.0% | Sold out | Holders |
| Q2 2024 | 12,925 | $5.52K | <0.1% | +12,925 | New | Holders |
| Q3 2023 | – | – | – | – | Not filed | Holders |
| Q2 2023 | 2,469,440 | $1.40M | 0.4% | +279,000+12.7% | Added | Holders |
| Q1 2023 | 2,190,440 | $1.37M | 0.5% | +395,650+22.0% | Added | Holders |
| Q4 2022 | 1,794,790 | $1.45M | 0.8% | +600,375+50.3% | Added | Holders |
| Q3 2022 | 1,194,415 | $1.02M | 0.6% | – | No prior filing | Holders |